Align Technology Opens 2024 Annual Research Program to Advance Orthodontic and Dental Patient Care

2024 Grant Application Process Now Open for Up to $300,000 in Funding

TEMPE, Ariz.–(BUSINESS WIRE)–Align Technology, Inc. (NASDAQ: ALGN) today announced the opening of its 2024 Annual Research Award Program to support clinical and scientific dental research in universities across the globe. This year, up to $300,000 will be awarded to university faculty for scientific and technological research initiatives to advance patient care in the fields of orthodontics and dentistry. Align Technology’s Research Award Program has funded approximately $3 million in research since the program’s inception in 2010.


“This program is an exciting opportunity for university researchers globally to expand scientific and clinical learnings to elevate patient care,” said Dr. Mitra Derakhshan, Align senior vice president, global clinical. “We look forward to the topics and research studies that may ultimately improve treatment outcomes and the quality of life for more patients worldwide.”

“Once again, we anticipate receiving a large number of applications to this research program. The topics submitted throughout the past years have been diverse and often on the forefront of the dental field. Align Technology is proud to fund this research program with the purpose of improving dental care throughout the world,” said John Morton, Align vice president, product innovation and technical fellow.

Awards available for dental research at universities are available in the following regions:

Americas (US, Canada, Mexico, Central and South America): Four one-year awards of up to US$25,000 each

EMEA: Four one-year awards of up to US$25,000 each

APAC: Four one-year awards of up to US$25,000 each

Eligible applicants for dental research awards include full-time and part-time faculty involved in dental or scientific research at universities where Invisalign® treatment or the iTero™ scanner is available. All applications are reviewed by an independent academic committee that forwards its recommendations to Align for final selection. Consideration will be given to first-time applications from a university program. Program details, instructions, and application forms for prospective applicants can be found at https://learn.aligntech.com/pages/61/resources (for Americas, EMEA and APAC applicants). Research proposals and completed applications must be received by 5:00 p.m. Pacific Time on March 8, 2024. Award recipients will be notified by June 3, 2024.

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for over 252 thousand doctor customers and is key to accessing Align’s 600 million consumer market opportunity worldwide. Over the past 26 years, Align has helped doctors treat 16.4 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign system or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Contacts

Align Technology
Madelyn Valente

(909) 833-5839

[email protected]

Zeno Group
Sarah Johnson

(828) 551-4201

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.